Submitted by web@researchtop... on Wed, 08/07/2013 - 12:01
1st-line Tx 60 yo w/ unresectable mets 1 y after adj FOLFOX? Pt age at which you don’t want to use bev?
What is your usual recommendation for first-line therapy for a 60-year-old patient who presents with widespread, unresectable metastases (PS = 0) 12 months after completion of adjuvant FOLFOX for Stage III KRAS wild-type (wt) colon cancer?
The patient had fared well on adjuvant FOLFOX except for minimal peripheral neuropathy that resolved in 6 months.
Submitted by web@researchtop... on Wed, 08/07/2013 - 10:52
TARGET AUDIENCE
This activity is intended for medical oncologists, hematologist-oncologists, hematology-oncology fellows, oncology nurses, radiation oncologists, colorectal-general surgeons and other healthcare practitioners involved in the management of colorectal cancer.
OVERVIEW OF ACTIVITY
Submitted by web@researchtop... on Tue, 08/06/2013 - 13:46
Submitted by web@researchtop... on Fri, 07/19/2013 - 11:57
Submitted by web@researchtop... on Fri, 07/19/2013 - 11:53
Submitted by web@researchtop... on Fri, 07/19/2013 - 11:51
Submitted by web@researchtop... on Fri, 07/19/2013 - 11:48
Submitted by web@researchtop... on Fri, 07/19/2013 - 11:38
Submitted by web@researchtop... on Fri, 07/19/2013 - 11:16
Submitted by web@researchtop... on Fri, 07/19/2013 - 11:11
Submitted by web@researchtop... on Fri, 07/19/2013 - 11:07
Submitted by web@researchtop... on Fri, 07/19/2013 - 11:05
Submitted by web@researchtop... on Fri, 07/19/2013 - 11:01
Submitted by web@researchtop... on Fri, 07/19/2013 - 10:58
Submitted by web@researchtop... on Fri, 07/19/2013 - 10:52